Pacific Biosciences
PACB
#7291
Rank
โ‚ฌ0.50 B
Marketcap
1,60ย โ‚ฌ
Share price
-3.83%
Change (1 day)
5.17%
Change (1 year)

EPS for Pacific Biosciences (PACB)

EPS in 2026 (TTM): -0,37ย โ‚ฌ

According to Pacific Biosciences 's latest financial reports the company's current EPS (TTM) is -0,39ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,68ย โ‚ฌ a decrease over its 2024 EPS that were of -1,04ย โ‚ฌ.

EPS history for Pacific Biosciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,37ย โ‚ฌ-77.93%
2025-1,68ย โ‚ฌ61.4%
2024-1,04ย โ‚ฌ-5.79%
2023-1,10ย โ‚ฌ-13.57%
2022-1,28ย โ‚ฌ57.3%
2021-0,81ย โ‚ฌ-841.67%
20200,11ย โ‚ฌ-121.79%
2019-0,50ย โ‚ฌ-28.49%
2018-0,70ย โ‚ฌ-13.48%
2017-0,81ย โ‚ฌ
2015-0,39ย โ‚ฌ-54.26%
2014-0,86ย โ‚ฌ-25.98%
2013-1,16ย โ‚ฌ-25.29%
2012-1,55ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
17,31ย โ‚ฌ-4,516.28%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
7,96ย โ‚ฌ-2,130.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
5,37ย โ‚ฌ-1,469.77%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
7,02ย โ‚ฌ-1,890.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-3,22ย โ‚ฌ 720.93%๐Ÿ‡บ๐Ÿ‡ธ USA